Durability of Sustained Virologic Response and Improvement of Fibrosis Markers after Daclatasvir and Asunaprevir Treatment in Genotype 1b Hepatitis C Virus-Infected Patients: a Real Life and Multicenter Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Durability of Sustained Virologic Response and Improvement of Fibrosis Markers after Daclatasvir and Asunaprevir Treatment in Genotype 1b Hepatitis C Virus-Infected Patients: a Real Life and Multicenter Study

Published:2019 Issue:41 Volume:34 Page:
ISSN:1011-8934
Container-title:Journal of Korean Medical Science
language:en
Short-container-title:J Korean Med Sci

Author:

Shin Seung Kak¹^ORCID,Lee Jin-Woo²^ORCID,Ra Hannah¹^ORCID,Kwon Oh Sang¹^ORCID,Shin Jong-Beom²^ORCID,Jin Young-Joo²^ORCID,Lee Sangheun³^ORCID,Han Ki Jun³^ORCID,Kim Young Nam⁴^ORCID,Kim Tae Hun⁵^ORCID,Kim Yun Soo¹^ORCID,Kim Ju Hyun¹^ORCID

Affiliation:

1. Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.

2. Department of Internal Medicine, Inha University School of Medicine, Incheon, Korea.

3. Department of Internal Medicine, International St. Mary's Hospital, Catholic Kwandong University College of Medicine, Incheon, Korea.

4. Department of Internal Medicine, Cheju Halla General Hospital, Jeju, Korea.

5. Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea.

Publisher

Korean Academy of Medical Sciences

Subject

General Medicine

Link

https://synapse.koreamed.org/pdf/10.3346/jkms.2019.34.e264

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What is the Long-term Benefit of Direct-acting Antiviral Therapy in Chronic Hepatitis C?;Journal of Korean Medical Science;2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP